mutations and sophisticated kar yotype. It follows a linear evolution in the CLL clone with the recurrent acquisition of CDKN2AOver the past decades, the volume of individuals referred for allogeneic hematopoietic cell transplantation has dropped significantly,133 although the treatment need to be advisable to younger/in shape clients in whom BCR/B